AHealth2b

 
Case 1
Subjective Data
CC: “I came for my annual physical exam, but do not want to be a burden to my daughter.”
History of Present Illness (HPI): At-risk 86-year-old Asian male – who is physically and financially dependent on his daughter, a single mother who has little time or money for her father’s health needs.
PMH: hypertension (HTN), gastroesophageal reflux disease (GERD), b12 deficiency and chronic prostatitis
PSH: S/P cholecystectomy
Drug Hx:
Current Meds: Lisinopril 10mg daily, Prilosec 20mg daily, B12 injections monthly, and cipro 100mg daily.
Review of Systems (ROS)
General: + weight loss of 25 lbs over the past year; no recent fatigue, fever or chills.
Head, eyes, ears, nose & throat (HEENT): no changes in vision or hearing, no difficulty chewing or swallowing.
Neck: no pain or injury
Respiratory:
CV:
GI:
GU: no urinary hesitancy or change in urine stream
Integument: multiple bruises on his upper arms and back.
MS/Neuro: + falls x 2 within the last 6 months; no syncopal episodes or dizziness
Psych:
Objective Data
PE: B/P 188/96; Pulse 89; RR 16; Temp 99.0; Ht 5,6; wt 110; BMI 17.8
HEENT: Atraumatic, normocephalic, PERRLA, EOMI, arcus senilus bilaterally, conjunctiva and sclera clear, nares patent, ornasopharynx clear, edentulous.
Lungs: CTA AP&L
Cor: S1S2 without rub or gallop
Abd: benign, normoactive bowel sounds x 4
Ext: no cyanosis, clubbing or edema
Integument: multiple bruises in different stages of healing – on his upper arms and back.
Neuro: No obvious deformities, CN grossly intact II-XII
Case 2
Subjective Data
CC: “I am here for my annual physical exam and have been having vaginal discharge.”
History of Present Illness (HPI): 32-year-old pregnant lesbian – her pregnancy has been without complication thus far. She has been receiving prenatal care from an obstetrician. She received sperm from a local sperm bank.
Drug Hx:
Current Medications: prenatal vitamins and takes Tylenol over the counter for aches and pains on occasion
Family Hx: She a strong family history of diabetes. Gravida 1; Para 0; Abortions 0.
Review of Systems (ROS)
General: no fatigue, fever or chills.
Head, eyes, ears, nose & throat (HEENT):
Neck: no pain or injury
Respiratory:
CV:
GI:
GU:
Integument: multiple piercings, and tattoos. Old scars related to “cutting”.
Neuro: no syncopal episodes or dizziness, no change in memory or thinking patterns; no twitches or abnormal movements
Objective Data
PE: B/P 128/76; Pulse 83; RR 16; Temp 99.0; Ht 5,6; wt 128; BMI 20.98
HEENT: Atraumatic, normocephalic, PERRLA, EOMI, conjunctiva and sclera clear; nares patent, ornasopharynx clear, good dentition. Piercing in her right nostril and lower lip.
Lungs: CTA AP&L
Cor: S1S2 without rub or gallop
Abd: benign, normoactive bowel sounds x 4
GU: external genitalia intact, no lesions or masses. White copious discharge with an amine odor; no cervical motion tenderness; adenxa intact.
Ext: no cyanosis, clubbing or edema
Integument: intact without lesions masses or rashes.
Neuro: No obvious deficits and CN grossly intact II-XII
Case 3
Subjective Data
CC: “Annual physical exam”
History of Present Illness (HPI): 23-year-old Native American male comes in to see you because he has been having anxiety and wants something to help him. He has been smoking “pot” and says he drinks to help him too. He tells you he is afraid that he will not get into Heaven if he continues in this lifestyle.
Drug Hx:
Current medication – denied
Allergies: no allergies to food or medications.
Family history: is very positive for diabetes, hypertension, and alcoholism.
Review of Systems (ROS)
General: no recent weight gains of losses, fatigue, fever or chills.
Head, eyes, ears, nose & throat (HEENT):
Neck:
Respiratory:
CV: no chest discomfort or palpitations
GI:
GU:
Integument: history of eczema – not active
MS/Neuro: no syncopal episodes or dizziness, no change in memory or thinking patterns; no twitches or abnormal movements
Psych:
Objective Data
PE: B/P 158/90; Pulse 88; RR 18; Temp 99.2; Ht 5,7; wt 208; BMI 32.6
General: 23 year old male appears well developed and well nourished. He is anxious – pacing in the room and fidgeting, but in no acute distress.
HEENT: Atraumatic, normocephalic, PERRLA, EOMI, sclera with mild icterus, nares patent, ornasopharynx clear, poor dentition – multiple carries.
Lungs: CTA AP&L
Cor: S1S2, +II/VI holosystolic murmur; without rub or gallop
Abd: benign, normoactive bowel sounds x 4; Hepatomegaly 2cm below the costal margin.
Ext: no cyanosis, clubbing or edema
Integument: intact without lesions masses or rashes.
Neuro: No obvious deficits and CN grossly intact II-XII
================================================================================================================
To prepare:

Select one of the three case studies. Reflect on the provided patient information.
Reflect on the specific socioeconomic, spiritual, lifestyle, and other cultural factors related to the health of the patient you selected.
Consider how you would build a health history for the patient. What questions would you ask, and how would you frame them to be sensitive to the patient’s background, lifestyle, and culture? Develop five targeted questions you would ask the patient to build his or her health history and to assess his or her health risks.
Think about the challenges associated with communicating with patients from a variety of specific populations. What strategies can you as a nurse employ to be sensitive to different cultural factors while gathering the pertinent information?
================================================================================================================
Post an explanation of the specific socioeconomic, spiritual, lifestyle, and other cultural factors associated with the patient you selected. Explain the issues that you would need to be sensitive to when interacting with the patient, and why. Provide at least five targeted questions you would ask the patient to build his or her health history and to assess his or her health risks.

Tackling Obesity in primary school children

 
Select three pieces of varied evidence relating to your chosen issue. Explain what they are, giving the rationale for your selection, and commenting on their strengths and limitations. (60% of the marks)
Reflect on the process of data search, selection and appraisal, indicating your search methods and what you see as key issues or dilemmas that emerged in this process. (40% of the marks)
Answer both parts of the question.

Improvements in the Manufacturing Industry Versus Health Care Industry

 
INSTRUCTIONS:

1) As health care looks at continuous improvement (as done in manufacturing), one of the most prominent questions that has arisen is, “Can the principles that worked in manufacturing really transfer over to health care? Taking care of a patient is not like building a car on an assembly line. Can standardized processes really work in a setting that focuses on humans and their needs?”
2) Write a paper of 825 – 1,200 words that takes a position on this argument. Justify the rationale for your position.
3) Refer to the assigned readings to incorporate specific examples and details into your paper.
4) Prepare this assignment according to the APA guidelines found in the APA Style Guide, located in the Student Success Center. An abstract is not required.
5) This assignment uses a grading rubric. Instructors will be using the rubric to grade the assignment; therefore, students should review the rubric prior to beginning the assignment to become familiar with the assignment criteria and expectations for successful completion of the assignment.

RUBRIC:

30.0 %A position is identified and justified with rationale. (Position is identified and justified with rationale.)
30.0 %Include information on the principles of productivity in manufacturing and how they may apply to health care. (Demonstrates thorough knowledge of the process of principles of productivity in manufacturing and how they may apply to health care. Clearly develops a strong analysis of the pros and cons. Introduces appropriate examples.)
10.0 %Integrates information from outside references into the body of paper. (Supports main points with references, examples, and full explanations of how they apply. Thoughtfully analyzes, evaluates and describes major points of the criteria.)
7.0 %Assignment Development and Purpose (Thesis and/or main claim are comprehensive. The essence of the paper is contained within the thesis. Thesis statement makes the purpose of the paper clear.)
8.0 %Argument Logic and Construction (Clear and convincing argument presents a persuasive claim in a distinctive and compelling manner. All sources are authoritative.)
5.0 %Mechanics of Writing (includes spelling, punctuation, grammar, language use) (Writer is clearly in command of standard, written, academic English.)
5.0 %Paper Format (Use of appropriate style for the major and assignment) (All format elements are correct.)
5.0 %Research Citations (In-text citations for paraphrasing and direct quotes, and reference page listing and formatting, as appropriate to assignment and style) (In-text citations and a reference page are complete and correct. The documentation of cited sources is free of error.)

LECTURE:

Working Harder Versus Working Smarter
Introduction
As health care entities begin the struggle to adapt to the changing environment that is being pressed upon them by the new health care reform legislation, the growing refusal of employer-based health plans to subsidize the cost of care provided to Medicare, Medicaid, and self-pay patients, and the increasing pressure to operate more effectively, there is increasing pressure to examine current system functioning for opportunities to improve. When revenues begin to diminish as double digit costs of care are reined in, it forces all entities in the health care delivery system to re-examine the processes and procedures of care delivery. The question of identifying and removing waste and inefficiency must be answered. In this module, we will examine some of the basic principles in which the quality and process improvement drive is grounded, how these principles have operated in health care agencies that have implemented them, and the lessons learned from those experiences.
Why Does This Have To Be Done?
In the early 1970s, the Japanese began to implement the lessons they learned from W. Edwards Deming after World War II by introducing high quality, lower cost cars into the American economy. There was a great rush to understand how they accomplished the feat of turning around their shattered manufacturing base and overcoming the image of cheap, easily broken or damaged goods coming from the East. Companies such as Toyota, Honda, Mitsubishi, Sony, and others began to create a new image, that of high quality at reasonable or lower costs. The Japanese economy began to rise in importance, becoming a financial powerhouse through several decades. Notwithstanding the issues of quality that have recently plagued Toyota in particular, it is still useful to study how the Japanese pulled it off. American manufacturing companies began to study Japan’s techniques and implement them. Chief among these were the focus on efficiency and effectiveness. However, during this period, health care providers remained distant and unengaged in looking at what they basically considered the business of manufacturing. Physicians and hospital executives reassured themselves that they were different, that the provision of health care was too complex and difficult to reduce it to an assembly line platform, that there were no lessons to be learned from car makers on how to help people back to a healthy state. During all this, health care costs continued to rocket to new levels, becoming an increasingly large component of the gross national product and driving health care expenses into double-digit levels year by year. However, by the early 1980s, the first cracks in the wall of indifference were beginning. When Medicare changed its method of compensating providers from a simple fee for service to a flat payment for diagnosis-related groups (DRGs) in 1983, it sent a shock wave through the health care community. That was followed over the next decade by many experiments in different payment methodologies. The message throughout was the same: health care costs were becoming too expensive for the nation to afford and had to be reduced. Slowly the system began to move in a different direction, but the changes came very slowly indeed. However, in the early 2000s, a general consensus began to emerge from all stakeholders that the system was not sustainable, both financially and from an outcomes perspective. The rate of medical errors, when revealed by the Institute of Medicine in the late 1990s, complicated the discussion, as the rate of increased cost did not correlate with hoped-for improvements in care. As mentioned in earlier modules, people who were not shielded from the true reality of health care costs by their employer-subsidized health insurance were getting a shocking introduction into charges from a hospital stay that could run into six figures. The Patient Protection and Affordable Care Act (PPACA), which was passed in March 2010, began the large task of attempting to control the rising spiral of health care costs through a variety of methods. Health care providers have become painfully aware of cuts in reimbursement, coupled with requiring hospitals to refund monies paid to them if they billed for the care that resulted from preventable errors. All providers are seeing the early rise of major system changes that must reduce costs over the long run and make a system that is sustainable for the distant future. Many of them are beginning to take a careful second look at the achievements seen by the formerly dismissed manufacturing facilities in reducing costs and improving quality of outcomes.
What Is Starting to Happen?
Hospitals in particular have always been the most expensive part of the health care continuum of care. Their focus on high-acuity patients who need focused patient care services and high technology to provide those services have also led to the highest costs in the system. Hospitals have begun to recognize that they must change their former ways of operating in favor of ways that allow them to reduce costs while improving quality and diminishing errors. The methods that came out of Japan appear to offer a road map on how to do this.
What are the common factors in the Japanese approaches?
There are multiple names for the improvement processes originally developed from the 14 Principles of W. Edwards Deming. They include LEAN, Six Sigma, Continuous Improvement, and several others. However, the bulk of them have very similar principles:
• Eliminate the waste of repeated mass inspections by building quality into each step of a work process, and enable all workers to “stop the line” to correct a problem at the moment rather than passing it on to someone else.
• Minimize total cost by standardizing processes and steps, thus reducing variation.
• Constantly improve every process and work function by vigilance, awareness, and a willingness to experiment with a better way.
• Break down barriers between departments, teams, and staff, so that work flows smoothly from one site to another.
• Promote seamless communication between all aspects of the process and all locations where the process happens.
• Eliminate all types of waste by removing non-value-added steps in each process, or steps that are unnecessary in order to achieve the final outcome.
These concepts are fundamental to a mindset of continuous improvement, which is the foundation for making changes that improve efficiency and effectiveness. It generally begins with dividing a defined process, such as the admission of a patient to a hospital, into its individual steps. This may take hours or even days, as various members of a redesign team observe the process in action, identify and measure each of the steps, and assess whether they provide value to the outcome of the process (in other words, are they essential to make the outcome occur?) Once this initial evaluation is completed, the redesign team then looks at each step to see if it can be eliminated, redesigned, or consolidated with another step in order to shorten the process. When the new process is finally assembled, it is then tested and monitored to ensure that it is functional, efficient, and effective in delivering the anticipated outcomes. It is also assessed for the need to retrain workers to use it. A measuring and monitoring plan is developed in order to determine if the process is being used, is working effectively, and is delivering outcomes. A communications plan to stakeholders must be designed and implemented, with the goal of building understanding and engagement on the part of all affected by the new process.
How Do These Concepts Work?
Some examples of how these concepts have been used in health care settings include the following:
1. A team of staff in a hospital magnetic resonance imaging department worried that their room turnover (the time it takes to remove one patient from the scanner, clean and prep the room, bring in the next patient, and begin the next scan) was too long. They examined their process by identifying its definition (the start step of the process and the end step of the process), its component steps, its expected outcomes, the time it took on average, and the resources it consumed. They then constructed a time line for each step, examined the value of each step, and looked for opportunities to improve. After removing several steps that they assessed as not adding value, and after looking at the process as two different processes that had been running consecutively, they came up with a new process that cut their average room turnover time from 18 minutes to 4 minutes. This resulted in an addition of up to one hour per day where they could scan additional patients, reducing patient waiting time for an appointment and increasing revenue. Since the staff, using internal consultants to help them, designed the new process, they were proud of the results and their efforts. Their implementation of the new process was seamless and is sustainable months after the change.
2. A surgery team was interested in finding ways to reduce the amount of time it took to set a room up for a surgical procedure. As they looked at their process and each of the steps, they found that approximately 30 to 40 minutes could be used up by the surgical tech in hunting down the correct surgical packs, trays, and instruments required by the surgeon for a particular case. They came up with a process that utilized prepacked trays and instruments that were prepared by an outside company and delivered on a cart to the surgical suite. The surgical tech simply wheeled the cart into the room, and the bulk of the supplies and equipment needed were immediately available. This reduced room prep time by 20 minutes or more per case.
3. An emergency department (ED) team felt that they were spending too much time counting the inventory of their supplies and restocking them on a daily basis. They reviewed their procedure, and implemented a new system that utilized two bins per supply item on the supply carts. One bin sat directly in front of the other, and each was stocked with the same supply and in the same amount. The ED staff pulled the supply item whenever they needed it, and when the first bin was empty, they placed it on a specified location in the supply storage area and pulled the second bin forward. The staff from central supply picked up the empty bin (which was labeled with the supply item and number to be placed in it), refilled it, and replaced it behind the bin that was currently in use. Thus, there was no need to count the supply each day, the caregivers never had to worry about running out, and the supply restocking process was simple for the central supply staff. Staff satisfaction with this system zoomed.
What Works and What Does Not?
When implementing this type of change, it requires continuous discipline, a relentless focus on the ultimate goals, and engagement of all parties affected by the change. It takes years to learn to do this type of fundamental culture change well. Some key issues to consider include:
• The need to involve physicians from the start. Particularly in the acute care setting, physicians are key to the success of any major change in process. In addition, they are also a key variable that contributes to variation from standard processes. Most physicians have developed their own patterns of care and preferences for equipment. Once they have become comfortable with these, it is very difficult to get them to change. The introduction of evidence-based practice changes can be very difficult for the surgeon, for instance, who has acceptable patient outcomes from his particular approach, but whose patients stay in the hospital two days longer than those of his colleagues. Physicians need to be active participants in looking at data, reviewing relevant research, and changing the protocols of care as a result. If they are not involved, the new change initiative will stop right at the physician’s order sheet. Physicians control the utilization of care resources to a major degree and are essential players to engage in this type of change.
• The need to involve staff from the start. In the examples listed above, the staff of the particular areas were the ones most familiar with current processes and opportunities for improvement. Once they were given the training and redesign support, they were creative and excited to take control of waste and inefficiency, which they had seen for years and felt helpless to do anything about. The engagement of staff is also important as a means to overcome the mindset of “this is how we’ve always done it”, which is often the most stubborn resistance-to-change factors of all.
• When involving staff, encourage them to experiment with changes that may make their work lives easier. The surgical techs who did not have to spend time chasing down equipment and supplies welcomed the idea of having their supplies delivered to their rooms on carts because it saved them time and effort. This is a powerful reinforcer to encourage staff to keep looking for other ways to become more efficient and reduce the amount of wasteful work they do.
• The importance of listing specific outcomes from the beginning. When the redesign teams know that they are looking for ways to accomplish a certain outcome, it helps them to stay focused during the design phase and gives them a benchmark to measure their progress against. If the outcomes are not achievable, it is the earliest indicator to back up, try again, and do something else in a different way.
• Set up display boards in each department so everyone knows what projects are in play and there is a consistent way to present new ideas for consideration. This enables people working on improvement teams to see the results of their progress. Measuring and monitoring outcomes is the last critical step in success.
Conclusion
There are a multitude of pressures on health care facilities and providers to find ways to reduce the rapidly growing costs of the current system. The methods that manufacturing has used for several decades to improve quality while reducing cost are now gaining a beachhead in the health care industry, and providers across the country are deeply engaged in learning how to use the techniques that Deming taught the Japanese with such startling results. An organization that is self-learning, constantly improving, and running efficiently is one that will survive the changes of health care successfully

Apharm3 Readings Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins. Chapter 19, “Hypertension” (pp. 230–246) This chapter examines the relationships between the cardiovascular, nervous, and renal systems. It then describes diagnostic criteria for hypertension patients, drugs used to treat hypertension and possible adverse reactions, monitoring patient response, and patient education. Chapter 20, “Hyperlipidemia” (pp. 247–262) This chapter explores causes of hyperlipidemia, treatments for hyperlipidemia patients, and methods for monitoring patient response. It also reviews strategies for risk assessment and patient education. Chapter 21, “Chronic Stable Angina” (pp. 263–277) This chapter begins by exploring factors that contribute to chronic stable angina, types of drugs used in treatment, and diagnostic criteria for initiating drug therapy. It also examines methods for monitoring patient response to treatment and educating patients on self-care. Chapter 22, “Heart Failure” (pp. 278–297) This chapter examines the process of prescribing drugs to treat heart failure and explores effects of prescribed drugs, proper dosages, and possible adverse reactions. Chapter 49, “Anticoagulation Disturbances” (pp. 764–803) This chapter covers drug therapy options for three disorders requiring anticoagulants: venous thromboembolism, atrial fibrillation, and ischemic stroke. It also explains the process of initiating and managing drug therapy for patients with these disorders. Drugs.com. (2012). Retrieved from https://www.drugs.com/ ================================================================================================================ Consider the following case studies: Case Study 1: Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following: Atenolol 12.5 mg daily Doxazosin 8 mg daily Hydralazine 10 mg qid Sertraline 25 mg daily Simvastatin 80 mg daily Case Study 2: Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following: Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun Aspirin 81 mg daily Metformin 1000 mg po bid Glyburide 10 mg bid Atenolol 100 mg po daily Motrin 200 mg 1–3 tablets every 6 hours as needed for pain Case Study 3: Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following: Glipizide 10 mg po daily HCTZ 25 mg daily Atenolol 25 mg po daily Hydralazine 25 mg qid Simvastatin 80 mg daily Verapamil 180 mg CD daily ================================================================================================================ To prepare: 1))Review Chapters 19 and 20 of the Arcangelo and Peterson text. 2))Select one of the three case studies, as well as one the following factors: genetics, gender, ethnicity, age, or behavior factors. 3))Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes. 4))Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy. 5))Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient. ================================================================================================================ Post an explanation of how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you selected. Then, describe how changes in the processes might impact the patient’s recommended drug therapy. Finally, explain how you might improve the patient’s drug therapy plan.

Apharm3
his chapter examines the relationships between the cardiovascular, nervous, and renal systems. It then describes diagnostic criteria for hypertension patients, drugs used to treat hypertension and possible adverse reactions, monitoring patient response, and patient education.

This chapter begins by exploring factors that contribute to chronic stable angina, types of drugs used in treatment, and diagnostic criteria for initiating drug therapy. It also examines methods for monitoring patient response to treatment and educating patients on self-care.

This chapter examines the process of prescribing drugs to treat heart failure and explores effects of prescribed drugs, proper dosages, and possible adverse reactions.

This chapter covers drug therapy options for three disorders requiring anticoagulants: venous thromboembolism, atrial fibrillation, and ischemic stroke. It also explains the process of initiating and managing drug therapy for patients with these disorders.

================================================================================================================
Consider the following case studies:
Case Study 1:
Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:
Atenolol 12.5 mg daily
Doxazosin 8 mg daily
Hydralazine 10 mg qid
Sertraline 25 mg daily
Simvastatin 80 mg daily
Case Study 2:
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following:
Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 1–3 tablets every 6 hours as needed for pain
Case Study 3:
Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
Glipizide 10 mg po daily
HCTZ 25 mg daily
Atenolol 25 mg po daily
Hydralazine 25 mg qid
Simvastatin 80 mg daily
Verapamil 180 mg CD daily
================================================================================================================
To prepare:
1))Review Chapters 19 and 20 of the Arcangelo and Peterson text.
2))Select one of the three case studies, as well as one the following factors: genetics, gender, ethnicity, age, or behavior factors.
3))Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
4))Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
5))Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
================================================================================================================
Post an explanation of how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you selected. Then, describe how changes in the processes might impact the patient’s recommended drug therapy. Finally, explain how you might improve the patient’s drug therapy plan.

SEE PAPER REQUIREMENTS

 
TASK DESCRIPTION
Closing the Gap in health equality between Aboriginal and Torres Strait Islander peoples and other Australians is an agreed national priority.
The nation wants continued focus and action in order to close the unacceptable health and life expectancy gap.
All political parties have committed to end the health equality gap by 2030, supported by almost 200,000 Australians who made the pledge.
Over the five-year period (2005-2007 to 2010-2012), life expectancy is estimated to have increased by 1.6 years for males and by 0.6 of a year for females. But a life expectancy gap of around ten years remains for Aboriginal and Torres Strait Islander people when compared with non-Indigenous people.

Australian Human Rights Commission. (2015). 2015 Close the gap Federal budget position paper. Retrieved from
https://www.humanrights.gov.au/sites/default/files/2015%20CTG%20Federal%20Budget%20position%20paper%20FINAL.pdf

The goal of inclusive practice is to be aware of, and responsive to, the needs of all people (De Chesnay, 2005, p. 18), and to provide health care based on the principles of social justice (Royal College of Nursing [RCN], 2008). In this context it means that as health professionals we also work to understand and break down barriers of inequality in access to health care. Our goal is to improve the health of all people, irrespective of their background, culture or beliefs.

YOUR TASK IN TWO PARTS-
1. First collect two current on-line or print news articles on Closing the Gap, and Aboriginal and Torres Strait Islander peoples’ health. Critique each article and discuss how it relates to inclusive practice and equity in health care.

2. Then you are to then critically examine, and provide evidence of the impact of Australian health policy and healthcare practices on health outcomes for Aboriginal and Torres Strait Islander peoples. Specifically you are choose three of the Close the Gap targets and strategies that have been put into place to achieve these targets.

YOUR ASSESSMENT WILL BE MARKED ON THE FOLLOWING CRITERIA-
-Structure
-Approach and argument
-Referencing

INSTRUCTIONS TO STUDENTS
When addressing the assignment topic you will need to use contemporary literature (mostly <5 years) to support your discussion.
It is expected that you will write in the third person, read widely around the topic and correctly reference your paper using the APA 6th edition referencing style.
Please note: referencing constitutes 15% of the overall grade for this assessment.

A 2000 word limit has been set for this assignment. A 10% leeway on either side of the word limit will be accepted. Word count will be measured from the first word of the introduction to the last word of the conclusion and include in-text referencing. Not included in the word count are the contents page and reference list.

To help scaffold your assessment you should allow approximately 10% (150-200 words) each for the introduction and conclusion, 200 words each for the news articles, which leaves 1200 words for the body.

Both news articles must be attached as appendices to your assignment.

Submit your Assessment Task 1 by the due date. Please include a cover page with student name, student number, course code, term date and year, name of course coordinator, name of assignment, and due date for submission. Remember to include a header with your student name and student number, and footer with the page numbers.

The Role of Pharmacist – To Prevent Prostate Cancer

2 Recent Articles (less than 10 years old) about how to prevent prostrate cancer. This coursework is about The main role of a pharmacist can prevent prostate cancer. What can the pharmacist do! to show early detection of prostrate with back up journals, how can they can prevent it.

Course Project: Community Advocacy Project—Health Policies

 
Course Project: Community Advocacy Project—Health Policies

To prepare for this section of the Course Project:

• Review the Windome et al. article. Reflect on the authors’ seven lessons and how the lessons apply to advocacy work and policy formation.
• Consider existing policies that impact the public health issue (TOBACCO USE) you selected in Week 1.. For instance, if you have identified tobacco use as an issue within your community, think about community policies that would curtail tobacco use such as tobacco-free zones and high taxes on tobacco products.
• View the media titled “Improving Public Health Policy.” Think about new policies that might be enacted to address your selected public health issue. These policies must be able to be implemented. Do not suggest, for instance, that smoking should be made entirely illegal.
• Identify potential stakeholders in the development and passage of ideas for health policy change within your community.

The Project (1–2 pages)
To complete this section of your Course Project, address the following:
• Describe existing policies that impact your selected public health issue (TOBACCO USE). Explain whether these existing policies are adequate or need to be revised based on their strengths and limitations, and why.
• Describe new policies that you consider important for addressing your selected public health issue, and explain why.
• Describe potential stakeholders in the development and passage of ideas for public health policy change within your community, and explain why their role is important.
Support your Project with specific references to all resources used in its preparation. You are asked to provide a reference list for all resources, including those in the Learning Resources for this course.

Physical activity and health in practice

 
Hi, my paper consists of 2 essay questions.

Q1 requires 2 pages with 10 references from only journals please, Q2 requires 2 pages with references only from journals.

Q1. THE START ACTIVE STAY ACTIVE 2010 CHIEF MEDICAL OFFICER’S GUIDELINE STATE THAT CHILDREN SHOULD ACCRUE 60 MINUTES OF MODERATE TO VIGOROUS PHYSICAL ACTIVITY EVERY DAY, AND MINIMISE THE TIME BEING SPENT SEDENTARY. CRITICALLY DISCUSS THIS GUIDELINE.

Q2.CRITICALLY DISCUSS PHYSICAL ACTIVITY INTERVENTIONS THAT DRAW ON SELF-DETERMINATION THEORY IN THEIR DESIGN.

NOTE: BOTH ANSWERS REQUIRE CLEAR INTEGRATION OF SUPPORTING EVIDENCE AND CONSIDERATION OF HEALTH OF INDIVIDUAL AND COMMUNITY LEVELS.

Medical Diagnosis: Crohn’s disease

Definition
Etiology and epidemiology
Pathophysiology
Specific lab indicators:
Medical Treatment
Medical Nutrition Therapy
References

write for me only the points required above
no need for introduction or conclusion
just write the required straight forward

Fetal Alcohol Syndrome and Native Americans–Theory of Planned Behavior

n

So the overall paper’s health topic is Fetal Alcohol Syndrome and our Health Behavior is consuming alcohol while pregnant. Our target population is Native American indian women aged 18-35 (but the age group doesnt really matter i guess) so the research you do will focus on that topic.

I will send the actual prompt/instructions so you have a better idea of what i need. You arent really going to do a whole research paper on the topic, you are only going to do one part of the paper. The part you will do is a “theory suggestion” (under that section in the prompt). The intrapersonal level theory you will do the paper on is THEORY OF PLANNED BEHAVIOR.

Just like the instructions say, you will need to provide an overview of the theory, explain each construct/concept/variable and apply it to the health behavior (alcohol consumption while pregnant) and health topic (fetal alcohol syndrome), say why the theory is applicable to the health issue, population, and behavior, explain why this theory is a good one to use to address the problem and to improve behavior among the population, explain if the theory has been used before for addressing this public health issue, explain how the theory is measured and also explain the strengths and weaknesses of the theory in regards to the health topic, behavior and population.

I will give some info on the theory of planned behavior so it can help you undertand it better. here is a link of a brief summary of what the theory is. https://sphweb.bumc.bu.edu/otlt/MPH-Modules/SB/SB721-Models/SB721-Models3.html

for the attachment i’m going to send titled “theory at a glance” you can look on pages 16-18 and in the powerpoint i’m going to send you can just look browse it.

oh and for the sources/references, please use peer reviewed scientific sources for at least 3. thanks!

thanks in advance!! i am on a time crunch so please do not ask for a time extension as i need to give this part to my group before 2 am. The last time i used your company’s services my paper did not get turned in on time and i recieved a zero. Good luck and again thank you so much!!